Migraine

A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from a few hours to 3 days. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity. Up to one-third of people affected have an aura: typically a short period of visual disturbance that signals that the headache will soon occur. Occasionally, an aura can occur with little or no headache following it. Migraines are believed to be due to a mixture of environmental and genetic factors. About two-thirds of cases run in families. Changing hormone levels may also play a role, as migraines affect slightly more boys than girls before puberty and two to three times more women than men. The risk of migraines usually decreases during pregnancy and after menopause. The underlying mechanisms are not fully known.

https://en.wikipedia.org/wiki/Migraine

Remedy Place Joins a Growing Trend of Health- and Wellbeing-Focused Social Clubs

Clients can also take a conference call from a Hyperbaric Chamber (for "optimal mental performance")...

discovered 4 months ago on Fashionista via Yahoo News
...to Host Investor R&D Call with Key Opinion Leaders Focusing on AXS-07 and the Unmet Needs in the...

AXS-07 is being evaluated in the ongoing MOMENTUM Phase 3 trial in migraine patients with a history of inadequate response to prior acute treatments, with topline results ...

discovered 4 months ago on Market Watch
Dreading the Flu Shot? More Needles Might Help

The makers of microneedle patches believe they’ve found a replacement for traditional vaccines and acute-migraine treatments, but challenges remain

discovered 4 months ago on The Wall Street Journal
Migraine Market Outlook Report 2019-2023: Company Profiling with Detailed Strategies, Industry Size,...

Nov 14, 2019 (Heraldkeepers) -- Migraine Market Analysis by types (Episodic and Chronic), by treatment type (Preventive and Abortive), by drug class (Triptans, Ergots, and ...

discovered 4 months ago on Market Watch
US trade restrictions have gone from being a headache to a migraine for FedEx — Contributions

Quartz is a guide to the new global economy for people in business who are excited by change. We cover business, economics, markets, finance, technology, science, design, and fashion.

discovered 4 months ago on Quartz
A new link between migraines, opioid overuse may be key to treating pain

About 10% of the world population suffers from migraine headaches, according to the National...

discovered 4 months ago on EurekAlert!
What it's like to experience "migraine with aura," a debilitating chronic health condition

My friend, who suffers countless food allergies, bolted to get me an antihistamine, which appeared...

discovered 4 months ago on Hello Giggles via Yahoo News
Ubrogepant Eases Acute Migraine Pain, New Data Confirm

Final results from the ACHIEVE II randomized, placebo-controlled trial confirm the safety and...

discovered 4 months ago on Medscape
New drug to fight migraine shows promise

The most common treatment against migraine is unsafe for people at risk of cardiovascular disease and stroke, but a new drug against migraine has shown...

discovered 4 months ago on CNN.com
Student, 19, scrawls note to colleagues during stroke

The former barista, who had been making coffee for a customer at the time, was rushed to A & E at Queen's hospital in Burton-upon-Trent by his mother, but had a migraine diagnosed ...

discovered 4 months ago on Daily Mail
New drug for migraine pain may suit more people than existing drugs

A new drug may alleviate agony for scores of migraine patients not deemed suitable to take existing...

discovered 4 months ago on Daily Mail
New Pill Halts Migraines in Progress

Migraine sufferers who cannot get relief from existing medications may soon have a novel treatment option, a new trial suggests. The study, of nearly...

discovered 4 months ago on Newsmax
New drug can relieve migraine pain in under two hours

For the estimated six million people in the UK who suffer migraine attacks, the new drug being...

discovered 4 months ago on MSN News
Every Question You Have About Getting a Cartilage Piercing, Answered

When it comes to ear piercings, you're likely familiar with the tried-and-true lobe variety you...

discovered 4 months ago on InStyle via Yahoo News
Axsome Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update

...topline results by year-end 2019 STRIDE-1 Phase 3 trial of AXS-05 in TRD to conclude patient screening in November 2019 with topline results expected in 1Q 2020 MOMENTUM Phase 3 trial of AXS-07 in migraine completed enrollment and on track for readout of topline results by year-end 2019 CONCERT...

discovered 4 months ago on Market Watch
Numb face: 5 causes and what to do

A numb face can be a symptom of one of many health conditions, including migraine and allergies. Problems with the nerves can sometimes be due to an...

discovered 4 months ago on Medical News Today
U.S. Military Gains Quicker Access to Migraine Relief through FDA-Cleared CEFALY Technology

NEW YORK, Nov. 5, 2019 /PRNewswire/ -- Move over lengthy approval process, a new partnership between...

discovered 4 months ago on Salamanca Press
Student struck by deadly meningitis he mistook for a hangover

-on-Severn, Worcestershire, woke up on October 14 feeling dreadful following a shift at a pub the...

discovered 4 months ago on Daily Mail
... Demonstrating the Promise of Remote Electrical Neuromodulation (REN) as First-Line Treatment for...

NETANYA, Israel, Nov. 8, 2019 /PRNewswire/ -- Theranica Bio-Electronics Ltd., a bio-medical...

discovered 4 months ago on Salamanca Press
'Rip My Skull Open' Pain: Non-Drug Remedy Offers Hope To Migraine Headache Sufferers

A small, battery-powered device can reduce the severity or even stop a migraine in its tracks,...

discovered 4 months ago on CBS New York
Migraine Drugs Market Worth of 6.5 Billion USD by 2025 | Major Market Players Share Analysis,...

Nov 07, 2019 (Heraldkeepers) -- The Global Migraine Drugs Market is expected to hold a value of USD 6.5 Billion by 2025 at a CAGR of 5.9%. Migraine is a ...

discovered 4 months ago on Market Watch
Vestibular Migraine: A Primer

Dr Shin C. Beh reviews the criteria and differential diagnoses for this condition.

discovered 4 months ago on Medscape
Trigeminal Nerve Stimulation May Head Off Migraine With Vertigo

External trigeminal nerve stimulation may be an effective treatment for acute vestibular migraine...

discovered 4 months ago on Medscape